The collagen-remodeling gene, COL5A1, was used in a 10-gene expression signature associated with poor patient survival in high-grade serous ovarian cancer and its expression appears to promote metastasis [69]. Here, COL5A1 is linked to ovarian serous adenocarcinoma.